Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Albuquerque, NM
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
New York, NY
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Stony Brook, NY
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Stony Brook, NY
Click here to add this to my saved trials
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Providence, RI
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Nashville, TN
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Galveston, TX
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Galveston, TX
Click here to add this to my saved trials
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
San Antonio, TX
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Webster, TX
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.
A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Webster, TX
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigator Site
mi
from
Birmingham, AL
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigator Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Mobile, AL
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Mobile, AL
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Phoenix, AZ
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Hot Springs, AR
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative site
mi
from
Los Angeles, CA
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Oceanside, CA
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Santa Monica, CA
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Arlington Heights, IL
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Champaign, IL
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Champaign, IL
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Skokie, IL
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Skokie, IL
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Indianapolis, IN
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Overland Park, KA
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigator Site
mi
from
Owensboro, KY
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigator Site
mi
from
Owensboro, KY
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative site
mi
from
Boston, MA
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
St. Louis, MO
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis
mi
from
Portland, OR
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis
mi
from
Portland, OR
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Greer, SC
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Greer, SC
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative site
mi
from
Dallas, TX
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative site
mi
from
Dallas, TX
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Houston, TX
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Houston, TX
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis
mi
from
San Antonio, TX
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Norfolk, VA
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Coral Gables, FL
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
East Windsor, NJ
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
East Windsor, NJ
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Forest Hills, NY
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Forest Hills, NY
Click here to add this to my saved trials
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Seattle, WA
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis
Status: Enrolling
Updated:  8/2/2016
Site Four
mi
from
Chicago, IL
Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis
Status: Enrolling
Updated: 8/2/2016
Site Four
mi
from
Chicago, IL
Click here to add this to my saved trials
Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis
Status: Enrolling
Updated:  8/2/2016
Site Two
mi
from
New Albany, IN
Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis
Status: Enrolling
Updated: 8/2/2016
Site Two
mi
from
New Albany, IN
Click here to add this to my saved trials
Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis
Status: Enrolling
Updated:  8/2/2016
Site One
mi
from
Louisville, KY
Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis
Status: Enrolling
Updated: 8/2/2016
Site One
mi
from
Louisville, KY
Click here to add this to my saved trials
Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis
Status: Enrolling
Updated:  8/2/2016
Site Three
mi
from
Las Vegas, NV
Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis
Status: Enrolling
Updated: 8/2/2016
Site Three
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/30/2016
International Dermatology Research, Inc.
mi
from
Miami, FL
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/30/2016
International Dermatology Research, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/30/2016
Minnesota Clinical Study Center
mi
from
Fridley, MN
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/30/2016
Minnesota Clinical Study Center
mi
from
Fridley, MN
Click here to add this to my saved trials
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/30/2016
Academic Dermatology Association
mi
from
Albuquerque, NM
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/30/2016
Academic Dermatology Association
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/30/2016
Dermatology Consulting Services
mi
from
High Point, NC
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/30/2016
Dermatology Consulting Services
mi
from
High Point, NC
Click here to add this to my saved trials
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/30/2016
J&S Studies
mi
from
College Station, TX
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/30/2016
J&S Studies
mi
from
College Station, TX
Click here to add this to my saved trials
Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects
A Single Dose Study Of The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics And Clinical Activity Of ILV-095 Administered Subcutaneously To Subjects With Psoriasis
Status: Enrolling
Updated:  1/5/2017
Pfizer Investigational Site
mi
from
Miami Gardens, FL
Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects
A Single Dose Study Of The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics And Clinical Activity Of ILV-095 Administered Subcutaneously To Subjects With Psoriasis
Status: Enrolling
Updated: 1/5/2017
Pfizer Investigational Site
mi
from
Miami Gardens, FL
Click here to add this to my saved trials
Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects
A Single Dose Study Of The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics And Clinical Activity Of ILV-095 Administered Subcutaneously To Subjects With Psoriasis
Status: Enrolling
Updated:  1/5/2017
Pfizer Investigational Site
mi
from
South Miami, FL
Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects
A Single Dose Study Of The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics And Clinical Activity Of ILV-095 Administered Subcutaneously To Subjects With Psoriasis
Status: Enrolling
Updated: 1/5/2017
Pfizer Investigational Site
mi
from
South Miami, FL
Click here to add this to my saved trials
Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects
A Single Dose Study Of The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics And Clinical Activity Of ILV-095 Administered Subcutaneously To Subjects With Psoriasis
Status: Enrolling
Updated:  1/5/2017
Pfizer Investigational Site
mi
from
Indianapolis, IN
Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects
A Single Dose Study Of The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics And Clinical Activity Of ILV-095 Administered Subcutaneously To Subjects With Psoriasis
Status: Enrolling
Updated: 1/5/2017
Pfizer Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects
A Single Dose Study Of The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics And Clinical Activity Of ILV-095 Administered Subcutaneously To Subjects With Psoriasis
Status: Enrolling
Updated:  1/5/2017
Pfizer Investigational Site
mi
from
Fort Gratiot, MI
Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects
A Single Dose Study Of The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics And Clinical Activity Of ILV-095 Administered Subcutaneously To Subjects With Psoriasis
Status: Enrolling
Updated: 1/5/2017
Pfizer Investigational Site
mi
from
Fort Gratiot, MI
Click here to add this to my saved trials